Bifurcated endoprosthesis for treatment of aortoiliac occlusive lesions

Manuel Maynar1, Tobias Zander, Zhong Qian

  • 1Hospiten Rambla, Las Palmas de Gran Canaria University, Santa Cruz de Tenerife, Spain.

Insights

Bifurcated stent-grafts offer a safe and effective endovascular solution for severe aortoiliac occlusive disease, improving blood flow and maintaining patency in patients with critical limb ischemia.

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Aortoiliac Disease Management

Background:

  • Aortoiliac occlusive disease (AIOD) presents a significant challenge in vascular surgery.
  • Severe cases, classified as TASC C or D, often require advanced treatment strategies.

Purpose of the Study:

  • To evaluate the initial clinical experience with bifurcated endoprostheses for AIOD.
  • To assess the safety and efficacy of this endovascular approach.

Main Methods:

  • A cohort of 5 patients with severe AIOD underwent endovascular treatment using a bifurcated stent-graft (Excluder).
  • Procedures involved preliminary recanalization followed by stent-graft placement.
  • Patients were monitored clinically and via ultrasound post-procedure.

Main Results:

  • Technical success was achieved in 100% of patients, with immediate restoration of iliac artery flow.
  • No procedure-related complications or mortality were reported.
  • Significant improvement in ankle-brachial index (ABI) from 0.66 to 0.94 (p<0.01), with sustained patency during a mean 17-month follow-up.

Conclusions:

  • Endovascular placement of bifurcated stent-grafts is a technically feasible and effective treatment for AIOD.
  • This approach demonstrates safety and efficacy in managing patients with severe aortoiliac occlusive disease.
Abstract